|
Written by Yael Waknine
|
|
Wednesday, 20 August 2008 |
Six new cases of hemorrhagic or necrotizing pancreatitis have been reported in patients using exenatide injection (Byetta, Amylin Pharmaceuticals, Inc), the US Food and Drug Administration (FDA) advised healthcare professionals today. |
|
Read more...
|